Colorobbia – Pilot Results

Basic Pilot Data

Company name: Colorobbia
Type of company:
Country:

logo Colorobbia

You do not have access to view this content.

Interview with Giovanni Baldi Director, Ce.Ri.Col – Colorobbia Consulting Research Centre

The videos below concern interviews with Giovanni Baldi  (Director Research Centre).

“We consider pivotal to our R&D efforts an open and continuous dialogue with stakeholders, patients, in the first place, and regulators, health-care professionals, policy makers, media, the society at large. It is vital to improve functionalities, quality and reliability, acceptability, of the NanoMed technologies and products.
With PRISMA we learned the importance of focusing on the ethical and social impacts of NanoMed since the early phases of the development, to become responsive and trustworthy toward needs and requests from users and society. This experience has convinced us of the strategic value of RRI for NanoMed and our organization.”

The first video is about the company and challenges faced.

 

This video is about the Safe by Design approach.

Case Description

The Company

You do not have access to view this content.

Commitment

You do not have access to view this content.

Context

You do not have access to view this content.

Materiality and Experimentation

You do not have access to view this content.

Validation Aspects (Key Performance Indicators)

You do not have access to view this content.

Responsible Research & Innovation (RRI) Roadmap

RRI Vision

You do not have access to view this content.

RRI Technologies and Products

You do not have access to view this content.

Drivers and Challenges for RRI

You do not have access to view this content.

Risks and Barriers to Be Addressed by RRI Actions

You do not have access to view this content.

RRI Approaches, Tools, Actions

You do not have access to view this content.

Roadmap Design

You do not have access to view this content.